Nano X Imaging Ltd (NNOX)

Currency in USD
0.99
-0.04(-3.92%)
Closed·
1.00+0.01(+1.01%)
·
Earnings results expected in 4 days
NNOX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.961.08
52 wk Range
0.734.71
Key Statistics
Prev. Close
0.99
Open
1.03
Day's Range
0.96-1.08
52 wk Range
0.73-4.71
Volume
2M
Average Volume (3m)
2.06M
1-Year Change
-78%
Book Value / Share
1.82
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NNOX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.13
Upside
+418.52%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Nano X Imaging Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.13
(+418.52% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Alliance Global Partners
Hold---DowngradeJul 07, 2026
Cantor Fitzgerald
Buy7.00+607.07%-MaintainDec 04, 2025
Cantor Fitzgerald
Buy6.00+506.06%-MaintainSep 22, 2025

Nano X Imaging Ltd SWOT Analysis


AI Imaging Revolution
Nano-X's innovative Nanox.ARC system and AI algorithms aim to transform medical imaging, potentially improving clinical outcomes and healthcare efficiency
Regulatory Milestones
FDA clearance for full-body scans and progress towards CE Mark approval position Nano-X for broader market penetration and international expansion
Market Potential
Analysts estimate a $3.5 billion annual revenue opportunity across healthcare sectors, with expanded FDA indications potentially driving higher system utilization
Financial Outlook
Despite mixed Q1 2024 results, analysts project significant revenue growth. Price targets range from $11 to $17, reflecting varied views on Nano-X's future prospects
Read full SWOT analysis

Nano X Imaging Ltd Earnings Call Summary for Q1/2026

  • Q1 revenue rose 53.6% to $4.3M but missed estimates by 26.1%; shares plunged 29.3% to $1.11, near 52-week low of $1.10.
  • Company withdrew $35M 2026 revenue guidance, citing unpredictable timing between commercial agreements and revenue recognition.
  • Net loss widened to $14.3M from $13.2M; cash burn hit $14M in quarter with $27M remaining, raising going-concern doubts.
  • Management expects Q2 revenue above Q1 with larger ramp in H2 2026 as distributor partnerships progress; 360 systems targeted over 2-3 years.
  • Operating expenses to decline via restructuring including 15-person headcount cut; AI breakeven expected before late 2026, cash breakeven early 2027.
Last Updated: 2026-06-25, 09:38 a/m
Read Full Transcript

Earnings

Latest Release
Jun 25, 2026
EPS / Forecast
-0.20 / -0.14
Revenue / Forecast
4.31M / 5.82M
EPS Revisions
Last 90 days

NNOX Income Statement

Compare NNOX to Peers and Sector

Metrics to compare
NNOX
Peers
Sector
Relationship
P/E Ratio
−0.9x8.2x−0.4x
PEG Ratio
0.030.400.00
Price/Book
0.5x2.7x2.6x
Price / LTM Sales
4.7x1.6x3.1x
Upside (Analyst Target)
-20.8%48.4%
Fair Value Upside
Unlock2.8%6.5%Unlock

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.17M4.55%3.23M
Other Institutional Investors
11.59M16.66%11.82M
Public Companies & Retail Investors
54.84M78.80%55.94M
Total
69.6M100.00%70.99M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Weiss Asset Management, LLC4.01%2,793,3392,849
UBS Asset Management AG1.94%1,349,2451,376

People Also Watch

4.31
GTM
+11.66%
10.23
STNE
+2.30%
2.88
ALT
-1.71%
18.42
SRPT
+0.22%

FAQ

What Is the Nano X (NNOX) Stock Price Today?

The Nano X stock price today is 0.99 USD.

What Stock Exchange Does Nano X Trade On?

Nano X is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nano X?

The stock symbol for Nano X is "NNOX."

What Is the Nano X Market Cap?

As of today, Nano X market cap is 68.65M USD.

What Is Nano X's Earnings Per Share (TTM)?

The Nano X EPS (TTM) is -1.15.

When Is the Next Nano X Earnings Date?

Nano X will release its next earnings report on Aug 18, 2026.

From a Technical Analysis Perspective, Is NNOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nano X Stock Split?

Nano X has split 0 times.

How Many Employees Does Nano X Have?

Nano X has 197 employees.

What is the current trading status of Nano X (NNOX)?

As of Aug 14, 2026, Nano X (NNOX) is trading at a price of 0.99 USD, with a previous close of 0.99 USD. The stock has fluctuated within a day range of 0.96 USD to 1.08 USD, while its 52-week range spans from 0.73 USD to 4.71 USD.

What Is Nano X (NNOX) Price Target According to Analysts?

The average 12-month price target for Nano X is 5.13 USD, with a high estimate of 7.4 USD and a low estimate of 3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +418.52% Upside potential.

What Is the NNOX After Hours Price?

NNOX's last after hours stock price is 1.00 USD, the stock has decreased by 0.01, or 1.01%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.